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ABSTRACT 
Aims 
Evaluating expression of the Human epidermal growth factor receptor 2 (Her2) by visual 
examination of immunohistochemistry (IHC) on invasive breast cancer (BCa) is a key part of 
the diagnostic assessment of BCa due to its recognised importance as a predictive and 
prognostic marker in clinical practice. However, visual scoring of Her2 is subjective and 
consequently prone to inter-observer variability. Given the prognostic and therapeutic 
implications of Her2 scoring, a more objective method is required. In this paper, we report on 
a recent automated Her2 scoring contest, held in conjunction with the annual PathSoc meeting 
held in Nottingham in June 2016, aimed at systematically comparing and advancing the state-
of-the-art Artificial Intelligence (AI) based automated methods for Her2 scoring. 
Methods and Results  
The contest dataset comprised of digitised whole slide images (WSI) of sections from 86 cases 
of invasive breast carcinoma stained with both Haematoxylin & Eosin (H&E) and IHC for 
Her2. The contesting algorithms automatically predicted scores of the IHC slides for an unseen 
subset of the dataset and the predicted scores were compared with the “ground truth” (a 
consensus score from at least two experts). We also report on a simple Man vs Machine contest 
for the scoring of Her2 and show that the automated methods could beat the pathology experts 
on this contest dataset. 
Conclusions  
This paper presents a benchmark for comparing the performance of automated algorithms for 
scoring of Her2. It also demonstrates the enormous potential of automated algorithms in 
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assisting the pathologist with objective IHC scoring.  
Key Terms: Digital Pathology, Automated Her2 Scoring, Biomarker Quantification, 
Quantitative Immunohistochemistry, Breast Cancer. 
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Introduction 
The adoption of image analysis in digital pathology has recently received significant attention 
due to the availability of digital slide scanners and the increasing importance of tissue-based 
biomarkers in stratified medicine [1]. Advances in software development and an upwards trend 
in computational capacity have also caused an upsurge of interest in digital pathology.   
Breast Cancer (BCa) is the most commonly diagnosed cancer among women, and the second 
leading cause of death worldwide [2]. According to Cancer Research UK, the risk for women 
being diagnosed with breast cancer is 1 out of 8 in the UK, and approximately 11,600 women 
died from breast cancer in 2012 [3]. In routine diagnostic practice of BCa, tumour tissue is 
stained with Haematoxylin and Eosin (H&E) and then examined under the optical microscope 
for morphological assessment including grade. In addition, tissues are stained by 
immunohistochemistry (IHC) to evaluate biomarker expression for prognostic and predictive 
purposes. This conventional method of diagnosis by visual examination is considered accurate 
in most areas but is known to suffer from inter-observer and intra-observer variability in some 
areas such as diagnosis of atypical hyperplasia and reporting of histological grade [4–6]. Digital 
pathology offers significant potential for improvement to overcome the subjectivity and 
improve reproducibility. 
 
Fig 1: Left to Right - Examples of regions of interest (800µm in height and the same in width) 
from WSIs scored 0, 1+ (negative), 2+ (equivocal), and 3+ (positive) 
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The human epidermal growth factor receptor 2 (Her2) gene is amplified in approximately 15-
20% of breast cancers [7]. Gene amplification can also be identified through Fluorescence In 
Situ Hybridisation (FISH). Alternatively, since Her2 amplification results in increased protein 
expression, IHC may be used. Given the technical ease of performing IHC, it has become the 
preferred test and FISH is usually only performed when the IHC is equivocal. In practice, an 
expert histopathologist will report a score between 0 and 3+ and cases scoring 0 or 1+ are 
classified negative whilst cases with a score of 3+ are classed as positive. Cases with score 2+ 
are classified as equivocal and are further assessed by FISH to test for gene amplification. 
Examples of the four different Her2 scores (0 to 3+) are shown in Fig 1. A summary of 
recommended guidelines for Her2 IHC scoring criteria [7] is shown in Table 1.  
Score Cell Membrane Staining Pattern Staining 
Assessment 
0 No membrane staining or incomplete membrane 
staining in < 10% of invasive tumour cells (0+) OR 
faint/barely perceptible or weak incomplete membrane 
stainaing in    > 10% of tumour cells (1+)  
Negative 
1+ Negative 
2+ A weak to moderate complete membrane staining is 
observed in > 10%  of tumour cells OR strong 
complete membrane staining in ≤10% of tumour cells 
Borderline 
(Equivocal) 
3+ A strong (intense and uniform) complete membrane 
staining is observed in > 10% of invasive tumour cells 
Positive 
 
Table 1: Recommended Her2 scoring criteria for IHC stained breast cancer tissue slides [7] 
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Historically, up to 20% of the Her2 IHC results may contain inaccuracies [8] due to variations 
in the technical quality and the subjective nature of scoring. Although adoption of Her2 
guidelines and recommendations [7], have served to improve standards in Her2 testing, there 
remain challenging cases especially with Her2 scores deemed borderlines between categories. 
Automated IHC scoring of Her2 carries promise to overcome the existing problems in 
conventional methods. Automated scoring methods are not prone to subjective bias and can 
provide precise quantitative analysis which can assist the expert pathologist to reach a 
reproducible score.  
The Her2 Scoring Contest, documented in this paper, was organized by the University of 
Warwick, the University of Nottingham and the Academic-Industrial Collaboration for Digital 
Pathology (AIDPATH) consortium (www.aidpath.eu). It was held in conjunction with the 
Pathological Society of Great Britain and Ireland meeting in Nottingham (June 2016) to 
provide a platform for researchers to assess the performance of computer algorithms for 
automated Her2 scoring on IHC stained slides. This paper provides an overview of the 
automated methods for Her2 scoring as presented at the contest and a Man vs Machine 
comparison of the degree of agreement among histopathologists and the automated methods 
for Her2 scoring. This may be considered as an initial step towards the development of a 
reliable computer-assisted diagnosis tool for Her2 scoring of digitised BCa histology slides. 
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Materials and Methods 
Ethics  
The ethics approval was by Nottingham Research Ethics Committee 2 [Approval No: REC 
2020313]; R&D reference (N) 03HI01. 
Image Data Acquisition and Ground Truth 
The histology slides for this contest were scanned on a Hamamatsu NanoZoomer C9600 
enabling the image to be viewed from a ×4 to a ×40 magnification, making the process 
comparable to a clinician’s standard microscope. Generally, WSIs are gigapixel images stored 
in a multi-resolution pyramid structure where the highest resolution is ×40. The contest dataset 
entailed 172 whole slide images (WSI) extracted from 86 cases of invasive breast carcinomas 
and included both the H&E and Her2 stained slides. The actual Her2 scoring is normally done 
on the IHC stained slides whilst the H&E slides assist the expert pathologist to identify the 
areas of invasive tumour and discriminate these from areas of in situ disease. Fig 2 shows an 
example of the two types of WSIs (with a corresponding zoomed-in region of interest) from 
the contest dataset.  
The ground truth (GT) was taken from the clinical reports issued on the cases at a tertiary 
referral centre for breast pathology (Nottingham University Hospitals, NHS Trust). At this 
centre, each case had been reported or reviewed by at least 2 specialist consultant 
histopathologists as part of their routine practice (preliminary reporting and MDT review). The 
centre provides regular internal quality control for Her2 assessment for immunohistochemistry 
runs and regularly contributes and participates in the UK NEQAS (National External Quality 
Assessment Scheme) for immunocytochemistry and in situ hybridisation (ICC & ISH). 
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Fig 2: An example WSI along with a zoomed-in cross-sectional area showing the tumour 
region (a) H&E stained slide (b) IHC stained slide 
Contestants 
A total of 105 teams from more than 28 countries registered to access the training dataset before 
the end of the registration deadline. By the end of submission deadline (off-site contest), a total 
of 18 submissions from 14 teams were received for evaluation. The organizers provided an 
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opportunity to each of the 14 teams for presenting their approach in the contest workshop and 
6 teams chose to present.  For the Man vs Machine contest, we received the markings from 4 
pathologists. The contest website was reopened for new submissions after concluding the 
workshop. Further details regarding various stages of the contest is described in Supplementary 
Material A. 
Evaluation 
The performance of each submitted algorithm was evaluated based on three criteria: 1) 
agreement points, 2) weighted confidence, and 3) combined points. Each assessment criterion 
has a separate leader-board.  
The evaluation criteria were rationalised according to the clinical significance and implications 
of Her2 IHC scoring as follows: in everyday clinical practice, for a score of 0 and 1+: No 
Herceptin is offered to the patient; for 3+ score, Herceptin is offered. For an IHC 2+ score, a 
FISH test is performed; if positive (i.e.) there is evidence of gene amplification and Herceptin 
is offered while for a negative result, it is not offered. The evaluation considers the impact of 
erroneous classification. For example, a score of 0/1+ being interpreted as 3+ or vice versa is 
a serious error while a 2+ scored as 0/1+ denies a few patients of valid treatment; a score of 3+ 
for a 2+ case bypasses the FISH test and may erroneously treat few cases (which would have 
been FISH negative) with toxic drugs while a score of actual 3+ downgraded to a 2+ calls for 
additional expense of FISH testing but the end result will probably be the same and hence this 
should not be regarded as that serious an error. These have been summarised in Table 2. 
For agreement points, a penalty method was employed whereby each erroneous prediction is 
penalised with respect to its deviation from the GT as shown in Table 2 (a). It can be envisaged 
that the agreement points may end in a tie, where the accumulative points of two or more teams 
may be the same. To resolve the tie, a bonus criterion was devised as shown in Table 2 (b), 
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where the decision was made on the percentage of cells with complete cell membrane staining 
(PCMS) regardless of the intensity. The bonus points were primarily introduced for score 2+ 
and 3+ as they attain more clinical significance. For the IHC score 1+, 1 bonus point was 
awarded if there was an accurate prediction of the IHC score and PCMS < 3%, while 3 bonus 
points were awarded if there was an accurate prediction of the IHC score and PCMS > 3% but 
the predicted PCMS value only deviated ±2% from the GT. For the IHC scores 2+ and 3+, 5 
bonus points were awarded if there was an accurate prediction of the IHC score and PCMS 
only deviated ±5% from the GT. Similarly, 2.5 bonus points were awarded for score 2+ and 
3+, if there was an accurate predication of IHC score and PCMS only deviated ±10% from the 
GT. 
 Predicted Score 
G
ro
u
n
d
 T
ru
th
 
Score 0 1+ 2+ 3+ 
0 15 15 10 0 
1+ 15 15 10 0 
2+ 2.5 2.5 15 5 
3+ 0 0 10 15 
 
Ground 
Truth Score 
Percentage of cells with complete cell 
membrane staining (PCMS) 
0 0 0 
1+ 1 (PCMS < 3%) 3 (PCMS ± 2) 
2+ 5 (PCMS ± 5) 2.5 (PCMS ± 10) 
3+ 5 (PCMS ± 5) 2.5 (PCMS ± 10) 
 
Table 2: (a) Agreement points for predicted calls of ground truth (GT), (b) Bonus point 
criteria, when PCMS lies in certain range of the GT value of the PCMS. 
The weighted confidence was devised to measure the credence of the predicted score by the 
submitted algorithm. The criteria to measure the weighted confidence 𝑤𝑐 were distinct for both 
truly and wrongly classified cases. In cases where the predicted Her2 score 𝑝𝑠 matched with 
(b) 
(a) 
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the GT with higher confidence 𝑐, the weighted confidence amplified the confidence value for 
true prediction whereas wrong predictions with high confidence were penalized accordingly, 
as given in equation (1). This kind of assessment is important for the development of an 
interactive diagnostic module. The confidence value may indicate those cases or regions where 
further examination by the experts may be required before concluding the final Her2 score. 
𝑤𝑐 = {
2𝑐−𝑐2
2
                 𝑖𝑓  𝑝𝑠 = 𝐺𝑇
 
 −𝑐2+ 1
2
                 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
     (1) 
The third assessment criterion is a combination of both agreement points and weighted 
confidence based evaluations. The combined points were calculated by taking the product of 
two assessment criteria for each case. 
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Results 
Contest Leaderboards 
Comprehensive results comprising all the submissions for automated methods are shown in 
Table 3. The teams in were ranked with respect to the combined-point based assessment with 
bonus points. For the off-site contest, the total possible points were 420 (28 cases with a 
maximum of 15 points each) whereas for weighted confidence, the maximum points were 28, 
1 for each case. The top three ranked teams with respect to point based assessments were Team 
Indus, MUCS-1, MUCS-2 whereas according to weighted confidence assessment the top 
ranked teams were VISILAB, FSUJena, MTB NLP. The combined results rank the top three 
team in the following order: VISILAB, FSUJena and Huangch. The performance of top-ranked 
teams including bonus points and the trend for total points (without the bonus points) can be 
seen in Fig 3. MUCS-1, MUCS-3, CS_UCCGIP and MTB NLP achieved equal points but 
MUCS-1 secured more bonus points as their PCMS was more accurate as compare to 
remaining counterparts. Similarly, Team VISILAB and Rumrocks ended up in a tie where both 
teams attained equal points but the VISILAB method was more precise in predicting PCMS. 
Comprehensive tables for all three leaderboards are available for download from the contest 
website. 
Summary of Proposed Automated Methods 
Most of the automated methods (described in Supplementary Material B) applied a supervised 
patch based classification approach to solve this problem. The most common pipeline was 
based on three main components: 1) pre-processing including the methods to identify the 
regions of interest for patch generation, 2) classification based on handcrafted or neural 
network learned features, and 3) post-processing techniques to aggregate the Her2 score at WSI 
level and to estimate the PCMS. Deep learning, especially Convolutional Neural Network 
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(CNN) based approaches dominated as 8 out of top 10 methods were based on CNN. The 
majority of the CNN architectures (Team Indus, MUCS-(1-3), MTB NLP, VISILAB, 
RumRocks, FSUJena) were inspired from the state-of-the-art deep neural networks [9,10]. 
 
Table 3: A summary of results of all three assessment criteria for  
the automated Her2 scoring contest, ordered by the combined points criterion.  
In pre-processing and patch extraction stage, most of the teams followed the conventional 
thresholding techniques with a combination of morphological operators. These techniques are 
computationally less expensive and generally work well as background regions lack any texture 
contents in contrast with other tissue components. The MUCS-(1-3), MTB NLP, VISILAB and 
FSUJena manually probe the regions of interest through some calibration or customized 
methodologies. These methods aimed to pick the best possible regions for training their 
algorithm, generally without affecting the testing phase. To segment tissue regions, the 
RumRocks team implemented a deconvolutional neural network (DCNN) and a 2D CNN being 
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for selection of patches based on their texture. The Huangch team performed mean filtering 
and stain normalization by using the control tissue intensity values to calibrate the stain colour 
intensity as a pre-processing step.  
 
Fig 3: Combined results for top ranked teams with respect to agreement and bonus points.The 
trend shows the significance of correclty predicting the percantage of cell membrane. 
In the second step, most of the teams (specifically top-10) employed deep learning approaches 
whereas other teams like CS_UCCGIP and Huangch derived handcrafted characteristic curves 
and employed standard machine learning approaches. Team Indus used a combination of data-
driven and handcrafted features. They incorporated the average control tissue intensity value 
along with learned features maps before passing them to the fully connected layers. Some of 
the top-ranked teams deployed variants of Alexnet [9] and GoogLeNet [10] for predicting the 
Her2 score. The FSUJena team computed the bilinear features after retrieving activations from 
convolutional layers of the AlexNet. The derived activations contain the learned feature maps 
representing a 𝑑-dimensional 𝑤 × ℎ spatial grid. This approach enables them to perform their 
analysis on top of the learned features maps from CNN. In combination with standard 
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approaches for data regularization, MTB NLP and RumRocks trained multiple models. The 
final Her2 score and PCMS was estimated by averaging over all the models. Additionally, a 
wide range of data augmentation and regularization techniques were employed to overcome 
the overfitting issues. As in practice, the standard data augmentation techniques such as affine 
transformations (e.g. rotation, flip, translation), random cropping, blurring and elastic 
deformations were applied to train the network.  MUCS-2, MTB NLP and RumRocks broadly 
used the data augmentation techniques to assist the network to generalize well on unseen data. 
In the final stage of pre-processing and predicting the PCMS, most of the teams employed 
standard image processing and machine learning approaches on top of the results attained from 
the last step. A Random Forest classifier was trained by MTB NLP to produce the final class 
probabilities and to estimate the PCMS. FSUJena simply used the mean tumour cell percentage 
seen in the training set for a particular class as an estimate. Team Indus used both IHC and 
H&E stained slides to estimate the PCMS by using standard image processing approaches like 
contour detection, thresholding and morphological features. All the remaining teams limited 
their analysis to only IHC stained images. All the submissions used high-magnification images 
(10× or above) except MUCS and Rumrocks who used images from low resolution for 
selection of ROIs. 
 
Man vs Machine Event  
Organization 
One way of evaluating the automated algorithms for IHC (Her2) scoring is to perform 
comparative analysis of the assessment of expert pathologists and automated methods for a 
handful of cases as compared to the scores for those cases as agreed by at least two consultant 
breast-pathologists (GT). On the day of contest workshop, we organized an event called as Man 
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vs Machine.  The main aim of this event was to analyse the performance of automatic methods 
and to explore the disagreements among conventional and automatic methods. This kind of 
analysis can lead us to a more sophisticated protocol for automatic Her2 scoring and to 
overcome the inter- and intra-observer agreements that can be found in normal practice.  
The analysis between the expert’s agreement and the evaluation of the automatic Her2 scoring 
method was performed with a subset (15 cases) of the off-site test dataset. For this event, we 
set up an online webpage for the pathologists. The webpage enabled the experts to load and 
navigate (including pan and zoom) through the WSI of those cases. Both IHC (Her2) and H&E 
stained digital images were made available to mimic the conventional scoring environment. 
We requested the expert pathologists on the contest day at PathSoc 2016 to score each case by 
providing the Her2 score, PCMS and a confidence value. 
 
Man vs Machine Results Comparison  
Table 4 summarizes the overall evaluation scores achieved by each participant for this event. 
Each table entry gives the cumulative score for all 15 cases, which indicates the overall 
performance. The agreement-points based assessment was used to evaluate the performance 
for this event. In total, we received 4 responses from expert pathologists and as shown in Table 
4, we ranked the top 6 submissions including the top 3 automated methods. From submitted 
responses, three participant pathologists reported themselves as ‘Consultant Pathologist’ and 
one as ‘Trainee Pathologist’ and all three of them marked breast pathology as a subspecialty.   
As can be seen in Table 4, one of the automated methods slightly outperformed the top-
performing participant pathologist. These results point to the potential significance of 
automated scoring methods and the recent advancements in digital pathology. It’s worth 
mentioning that automated Her2 scoring algorithms submitted in this contest are not ready to 
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deploy in their current form, as they will require extensive validation on a significantly large-
scale data and also plenty of input from experts to prepare the GT on the larger data.  
Rank Team Name Score Bonus Score + Bonus 
1 Team Indus 220 12.5 232.5 
2 Expert 2 210 20.5 230.5 
3 VISILAB 212.5 15 227.5 
4 MUCS-1 205 20.5 225.5 
5 Expert 1 185 10 195 
6 Expert 3 180 13 193 
 
Table 4: Summary Results for the Man vs Machine event. The evaluation was carried out 
according to the contest criteria as described in Evaluation Section. 
Table 5 shows pooled data for Her2 scoring among the three top-ranked automated methods 
and the scores from three participant pathologists and comparison with the GT. The Table 5 
was determined for the 15 cases selected from the off-site contest dataset. On the basis of Her2 
scores, a 100% agreement with the GT was observed for score 3+ among the participant 
pathologists and the automated methods. For the scores of 1+ and 2+, there were disparities 
between the GT and the new scores. In all cases bar one, for both man and machine, the error 
resulted from overcalling the score. Thus, for the score 1+, on 6/9 (67%) were overcalled as 2+ 
by humans whilst 4/9 (44%) were overcalled by the machine algorithms. For the score of 2+, 
7/15 (46%) were overcalled as 3+ by humans whilst machines overcalled 1/15 (6%) as 3+ and 
1/15 (6%) was undercalled as 1+. Clinically, score of 2+ is critical, as in routine practice cases 
of score 2+ are recommended to go through FISH testing. It’s equally important to avoid 
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predicting the score 2+ as 1+ or 0, cases such erroneous prediction will deny the further 
assessment of Her2. As it can be seen in Table 5, none of the cases with score 2+ was 
misclassified by the participant pathologists as either 1+ or 0 whereas for one of the case an 
automated method wrongly predicted a score of 2+ as 1+.   
 
Case 
Ground 
Truth 
FISH 
Results 
Expert 
1 
Expert 
2 
Expert 
3 
Team 
Indus 
Visilab 
MUCS-
1 
1 2+ Negative 3+ 2+ 2+ 2+ 2+ 2+ 
2 0 - 0 1+ 1+ 1+ 1+ 0 
3 3+ - 3+ 3+ 3+ 3+ 3+ 3+ 
4 0 - 1+ 1+ 1+ 0 1+ 1+ 
5 1+ - 2+ 1+ 2+ 1+ 2+ 1+ 
6 3+ - 3+ 3+ 3+ 3+ 3+ 3+ 
7 
2+ Borderline 
amplified  
3+ 3+ 3+ 2+ 2+ 2+ 
8 2+ Negative 3+ 2+ 3+ 2+ 3+ 2+ 
9 3+ - 3+ 3+ 3+ 3+ 3+ 3+ 
10 3+ - 3+ 3+ 3+ 3+ 3+ 3+ 
11 1+ - 1+ 1+ 2+ 0 1+ 1+ 
12 2+ Positive 2+ 2+ 3+ 2+ 2+ 2+ 
13 1+ - 2+ 2+ 2+ 2+ 2+ 1+ 
14 2+ Negative 2+ 2+ 2+ 2+ 2+ 1+ 
15 0 - 0 1+ 0 0 1+ 0 
16 
2+ Borderline 
amplified 
- - - 0 1+ 2+ 
17 2+ Negative - - - 2+ 2+ 2+ 
18 2+ Positive - - - 2+ 1+ 2+ 
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Table 5: Combined matrix for agreement among the three experts and the top three automated 
methods based on agreement points against the GT scores for 15 cases in the Man vs Machine 
event. The boderline case 7 was deemed negative and cases 16,19  were deemed positive for 
treatment decision (based on the HER2:CEP17amplification ratio for Her2 over-expression: 1.96, 
2.1 and  2.07 respectively). 
Most of the incorrect predictions by the participant pathologists were found to be in cases where 
there was considerable heterogeneity. Two such examples are shown in Fig 4 (a-d). In tumour 
cells of Her2 score 2+, a pattern of weak to moderate complete membrane staining is observed 
whereas for score 3+, an intense (uniform) complete membrane staining is observed. 
Estimating the complete membrane staining is a difficult and highly subjective process 
especially for score 2+ and 3+, as it is extremely hard to pick up subtle differences in the 
morphological appearance for those cases.  
 
19 
2+ Borderline 
amplified 
- - - 2+ 2+ 2+ 
20 1+  - - - - 1+ 1+ 1+ 
21 1+  - - - - 1+ 1+ 2+ 
22 0  - - - - 1+ 0 1+ 
23 1+  - - - - 0 1+ 1+ 
24 1+  - - - - 0 1+ 2+ 
25 3+  - - - - 3+ 3+ 3+ 
26 0  - - - - 1+ 0 1+ 
27 0  - - - - 0 0 1+ 
28 0  - - - - 0 0 0 
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Fig 4: Examples showing IHC stained WSIs (a & c) and zoomed-in cross sectional area (b & 
d) with corresponding Her2 GT scores marked by expert pathologists and predictions from top 
3 automated methods.  
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Discussion 
A major aim of organizing this contest was to provide a platform for computer scientists and 
researchers to contribute and to evaluate the performance of their computer algorithms for 
automated IHC scoring of Her2 in images from BCa tissue slides. Automated scoring can 
significantly overcome the subjectivity found due to varying standards adopted by different 
diagnostics labs. There is a current wealth of literature [11,12] using individual platforms (both 
freely and commercially available) for digital analysis of Her2 in BCa. This, however, was the 
first comparison of platforms and algorithms and provides a pilot for independent comparison 
of computing algorithms for Her2 assessment on a benchmark dataset. The contest highlights 
the wealth of potential carried by Artificial Intelligence (AI) techniques for assessment of IHC 
slides.  
The contest “training dataset” was deliberately selected in a way that it contained a reasonable 
number of cases from all Her2 scores bearing in mind the need for the training algorithms to 
learn features for each score. For the test dataset (both off-site and on-site), the GT was 
withheld at the time of image evaluation. Results showed that the automated analysis 
performed comparable to histopathologists. Many of the algorithms achieved high accuracy – 
often close to the maximum. Our main objective was to analyse the performance of algorithms 
based on clinical relevance and hence the three particular evaluation criteria described above 
were chosen. It may be possible that other assessment criteria may influence the ranking of 
comparative results.  
The data from the Man vs Machine comparison showed that, reassuringly, all participants 
(whether human or computer) correctly identified cases with GT score of 3+. This means that 
no-one in the category would have been denied treatment. Similarly, for the cases with a score 
of 0 or 1+, although there was some over-calling, this never exceeded 2+ and thus none would 
22 
 
have received treatment without further testing. The most problematic category was, not 
unexpectedly, cases with a score of 2+; in both human and machine evaluations. If overcalled 
as 3+, the FISH negative subset would be over-treated. The GT information for the FISH results 
were not released to the participants as the contest was aimed just at comparing interpretation 
of Her2 IHC results. Hence, most of the automated algorithms aimed at predicting the 
equivocal cases as 2+. Table 5 incorporates the FISH results for all the cases that were marked 
as 2+ in the test data GT (including Man vs Machine dataset). From Man vs Machine cases (15 
in total), a score of 2+ (subsequently FISH negative) was overcalled by the machine as 3+ in 
just one instance (VISILAB). In contrast, on three occasions (subsequently FISH negative) the 
participant pathologists overcalled the score 2+ as 3+. Moreover, for the remaining test dataset 
(13 cases), on three instances the score of 2+ (subsequently FISH positive) were erroneously 
predicted as either 1+ and 0 by the automated algorithms. Overall, the results indicate that 
further fine-tuning will be required for 2+ cases with AI. While it is encouraging that automated 
Her2 scoring algorithms may have sufficient potential, as direct comparison to human 
diagnosis, it is probably worthwhile to reflect that the number of pathologists actually joining 
the contest was small (only four) and it would have been better to compare the pathologist’s 
assessment of the slides on a reporting microscope rather than a computer for a fairer 
comparison to real life practice.  
Conventionally, expert pathologists often switch back and forth between the IHC and H&E 
slides to map the invasive tumour regions for estimating the percentage of complete membrane 
staining. Beside one of the participants (Team Indus), most of the algorithms reported in this 
paper have avoided the use of H&E slides, though one cannot rule out the use of H&E slide for 
automatic detection of DCIS regions. In addition, the task of predicting the PCMS is extremely 
subjective, as the expert has to make estimation on the basis of physical appearance of the 
stained invasive tumour region. The semi-automated methods could provide a comprehensive 
23 
 
quantitative analysis on selected region of interest to assist the experts in estimating the PCMS 
and Her2 score, especially on borderline cases. As Her2 immunoscoring relies not only on 
intensity but the completeness of membrane positivity, automated scoring may be helpful as 
demonstrated by Brügmann et al. [13] who proposed scoring of Her2 based on an algorithm 
evaluating the cell membrane connectivity.  
This study shows that automated IHC scoring algorithms can provide a quantitative assessment 
of morphological features that can assist in objective computer-assisted diagnosis and 
predictive modelling of the outcome and survival [14]. We have demonstrated the potential 
significance of digital imaging and automated tools in histopathology. In the context of breast 
histopathology, whereby almost all the invasive tumour cases are considered for Her2 testing, 
an automated or semi-automated scoring method has potential for deployment in routine 
practice. Despite of all these advancements, several challenges remain for the AI algorithms to 
be optimised and to become the part of routine diagnosis. It is worth noting that serious 
optimization will be needed for automated methods while processing a whole-slide image. 
Some methods required more than three hours per case, which, in the “real world” of diagnostic 
service delivery is not feasible.  Another limitation of this contest was that the image data were 
collected from a single site using a single scanner. A potential extension would be to collect 
data from multiple pathology laboratories with Her2 scores marked by different experts and 
images scanned using a variety of different machines. This would also test the differences 
inherent in staining quality that may affect such procedures. Such enhancements could 
significantly overcome the overfitting to one particular dataset that may occur in the automated 
scoring methods. In moving across systems, other laboratories for example, have 
acknowledged the challenges in reaching the optimum Aperio algorithm parameters to provide 
results that were equivalent to those of the ‘Automated Cellular Imaging System’ (ACIS) or 
‘Cell Analysis System’ (CAS 200) quantitation systems [15], which are fully automated 
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environments for detecting cells based on intensity characteristics and handcrafted features 
found in IHC stained images. Therefore, there is a need to learn across comparative systems 
for which the current study provided a valid starting point. Also, the study highlights the need 
of dialogue between histopathologists and informaticians to understand correct identification 
of tissue compartments relevant for assessment, correct morphology (normal vs in situ vs 
invasive) and stromal stain vs tumour stain. Algorithms will also need to be trained to the 
natural acceptable variation in staining hues and intensities (intra and inter-laboratories) to 
work effectively during routine practice.  
All cases with score 2+ are routinely recommended for further FISH testing to validate Her2 
overexpression at the gene level. It would be an added advantage if the automated methods 
could be trained with FISH GT to predict the final outcome and the potential for automated 
algorithms in calling the actual final Her2 status with reproducible accuracy could be 
demonstrated. For this, a larger series with 2+ cases alone with FISH data would need to be 
tested. Indeed, there have been promising other studies that indicate that automated image 
analysis for Her2 instead of manual assessment may reduce the need for supplementary FISH 
testing by up to 68% [16]. In a diagnostic setting, this would significantly reduce costs and 
turn-around time. During the last decade, IHC staining has become ubiquitous in pathology 
labs around the world and the role of IHC evaluation in a high-throughput setting becomes key 
for IHC based companion diagnostics. Other possible extensions of digital pathology could be 
to automate the overexpression of the programmed death 1 (PD-1) receptor and its ligand (PD-
L1), to evaluate anaplastic lymphoma kinase (ALK) protein and proto-oncogene tyrosine-
protein kinase ROS1 in lung cancers [17]. The AI based algorithms would be more effective if 
IHC staining and scoring methods were treated as a composite assay [18][19]. The varying 
staining protocols and scoring parameters may restrain the effectiveness of AI based automated 
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scoring algorithms including the Her2 scoring but with sufficiently variable data from different 
centres, AI algorithms could be trained to overcome that problem. 
This contest provides a baseline for computer science and computational pathology researchers 
for automated/semi-automated scoring and computer-assisted diagnosis (CAD) tools to assist 
the pathologists in daily routine analysis. The contest is now over but the registration and the 
web-portal will remain open for future participants to make novel contribution in automated 
Her2 scoring.   
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Supplementary Material A 
Contest Format 
The contest involved four stages, as described below. 
Stage 1: Release of the Training Data In first stage, a training dataset comprising 52 cases were 
released to the registrants on April 24, 2016 through a secure website portal1. The dataset 
consisted of IHC and H&E stained images and the ground truth (GT). The GT score and 
percentage cells with complete membrane staining for the released training dataset can be seen 
in Table 1. At this stage, most of the details regarding contest (like tasks, contest rules, contest 
forum details etc) were already posted to the contest website and the registered teams started 
their work on algorithms for Her2 scoring. The registration process remained open for five 
weeks. We also created a social-forum (Google group) for the participants to share their queries 
and to communicate with the organizers. 
Stage 2: Release of Off-Site Test Data A dataset comprising 28 cases were selected for off-site 
testing.  This test dataset was released on May 17, 2016 and consisted of IHC and H&E stained 
WSIs without the GT information to ensure a fair evaluation. Source code for performance 
assessment in both MATLAB and Python languages were also released to the registrants. The 
registrants were given more than a month after releasing the test data to finalize and submit 
their scoring methods for announced tasks. 
Stage 3: Submission of Results (Off-Site) The deadline for submission of results for the test 
dataset was set to be June 21, 2016, a week before to the contest workshop. Each team had to 
submit results in a comma-separated values (CSV) file along with a maximum 2-page summary 
of their algorithms, a description of experimental setup, and some preliminary results. The 
participants were advised that the CSV file should contain the predicted Her2 score, the 
confidence value for predicted score and the percentage of cells with complete cell membrane 
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staining (PCMS) for each WSI in the test dataset. Each registrant was allowed to submit up to 
three sets of results. The submitted results were evaluated but results were not announced until 
the contest workshop was held. 
Stage 4: Contest Workshop. The contest workshop was conducted in Nottingham in 
conjunction with the annual meeting of the Pathology Society of Great Britain and Ireland on 
June 29, 2016.  The contest workshop covered three main events: a) a brief talk from the 
organizers and the participants where 6 teams were invited for a small presentation to give an 
overview about their approaches and experiments, b) announcement of the comparative results 
of algorithms for both off-site, and c) announcement of results for the Man vs Machine 
comparison as a part of the on-site contests. The remaining 6 cases (of the 86) were used for 
an on-site competition (although they were released one day before the contest workshop due 
to the computational requirements of some of the automated algorithms and their results are 
not discussed here). The complete tables of results are available on the contest website2. 
 
Case Ground truth 
 
FISH 
Results 
Percentage cells with complete membrane staining 
irrespective of intensity 
1 0 N/A 0% 
4 2 Negative 60% 
6 2 Positive 40% 
9 3 N/A 70% 
11 3 N/A 90% 
12 1 N/A 5% 
13 0 N/A 0% 
14 1 N/A 1% 
                                                          
2 http://www.warwick.ac.uk/TIAlab/Her2Contest/  
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15 1 N/A 2% 
16 1 N/A 5% 
18 0 N/A 0% 
19 3 N/A 30% 
22 3 N/A 90% 
24 1 N/A 5% 
25 2 Negative 30% 
26 2 Positive 50% 
27 3 N/A 80% 
29 0 N/A 0% 
30 3 N/A 90% 
32 1 N/A 3% 
33 3 N/A 100% 
34 1 N/A 2% 
35 3 N/A 90% 
36 2 Positive 100% 
38 3 N/A 90% 
39 0 N/A 0% 
40 2 Positive 60% 
46 0 N/A 0% 
47 1 N/A 5% 
48 2 Positive 20% 
49 2 Positive 30% 
50 2 Positive 50% 
52 0 N/A 0% 
55 2 Positive 70% 
57 0 N/A 0% 
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58 1 N/A 5% 
61 3 N/A 90% 
63 2 Borderline 
amplified 
70% 
65 1 N/A 2% 
66 0 N/A 0% 
67 2 Positive 30% 
68 0 N/A 0% 
70 0 N/A 0% 
73 0 N/A 0% 
74 2 Positive 10% 
79 1 N/A 5% 
82 3 N/A 80% 
83 3 N/A 100% 
84 3 N/A 70% 
86 1 N/A 3% 
87 0 N/A 0% 
88 1 N/A 5% 
 
Table 1: The ground truth score for 52 cases from the training dataset with percentage of cells 
with complete membrane staining. The boderline case 63 was deemed negative and the 
amplification ratio for Her2 over-expression was 1.92.  
35 
 
Supplementary Material B 
Related Work on Automated IHC Scoring 
Automated image analysis is observed as a solution [1,2] to overcome the inter- and intra- 
observer variations found in conventional assessment of tissue slides. Hence, the automated 
scoring of routine H&E and IHC stained slides has received huge interest in recent years. In 
literature, several classical machine learning approaches [3–5] have been presented but recently 
deep learning based approaches have been profoundly employed for H&E and IHC histology 
image analysis [6,7].  
In literature, a wide range of handcrafted features was proposed for IHC scoring algorithms 
[4,5].  For instance, Choudhury et al. [8] proposed an averaged threshold measure (ATM) for 
scoring of digitized images of IHC stained tissue microarrays. A set of arbitrary chosen 
thresholds was selected, whereby an optimal threshold using the ATM is used for calculating 
the percentage of stained area. The proposed ATM statistic presented as a generalization of the 
HSCORE [9] statistic for scoring IHC slides. Reyes-Aldasoro et al. [10] presented an 
alternative approach for automated segmentation of microvessels in IHC tumor slides. For 
segmentation, distinguishing hues of stained vascular endothelial nuclei and tissue regions 
were explored to extract the seeds for a ‘region-growing’ model. Their post-processing of 
segmented microvessels from CD31 immunostaining contained three steps, closing 
morphological objects from tumour margins, combining isolated objects, and splitting objects 
into individual vessels with having multiple lumina. Although the thresholding approaches 
perform well on a specific dataset, they are likely to fare not as well on an unseen dataset as 
distinctive hues can be significantly varying. A potential reason of such variation lies in 
staining process, as the histology slides normally stained at different occasions with 
inconsistent concentrations often exhibit large variations in colour and appearance. Such 
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differences in slide preparation make the colour and morphological appearance of tissue 
components more unpredictable.  
Kuse et al. [11] used local isotropic phase symmetry measure as a significant feature for beta 
cell detection and lymphocytes. By calculating the peak of median phase energy after stain 
normalization but due to heterogeneous appearance and often-clumped structure makes nuclei 
segmentation a non-trivial task. Khan et al. [5] used stain quantization for the scoring of 
Estrogen Receptor (ER) and Progesterone Receptor (PR) by determining the amount of 
chromatin material and protein content from IHC stained WSIs. Ali et al. [12] used 
astronomical algorithms for the scoring of ER on IHC stained images of breast cancer. 
However, in this contest the classical machine learning approaches have been outperformed by 
deep learning approaches. Most of the published algorithms are based on different approaches 
with different dataset whereas this contest provides a platform where participants can develop 
and validate the performance of their algorithms on same dataset.  
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Description of Automated Methods  
The concise description of automated methods employed by top-ranked teams are described 
below. 
Team Indus 
In this approach, a deep convolutional neural network (CNN) was employed for predicting the 
Her2 score whereas for estimating the percentage of complete membrane staining, a set of 
handcrafted morphological features were extracted from H&E and IHC stained slides.  
Pre-processing: The patches with average edge strength lies higher then certain threshold were 
selected for training CNN. 
Her2 Score Prediction: The presented CNN architecture contains five convolutional layers, 
one concatenation layer with following two fully connected and one classification layer. After 
each convolution and fully connected layer, a ReLu activation was performed whereas for 
classification layer a softmax activation was placed. After convolution layers a concatenation 
layer was positioned. The concatenation layer combines the activation maps from the 
convolution layers and the average control tissue intensity for the corresponding WSI from 
which the patches were originated. The weights for training CNN were initialized using H&E 
normal initializations [13] and updated using mini batch gradient descent (learning rate = 
0.00015, weight decay = 10-6, Nesterov momentum = 0.95, batch size = 32). The CNN was 
trained over 41K patches generated each of size 224x224 from 52 training WSIs for 65 epochs. 
 
During testing, the trained network assigned a score to each patch of a WSI and to aggregate 
the patch scores into a single Her2 score following criteria was proposed. Let n0, n1, n2 and n3 
be the number of patches scored as 0, 1+, 2+ and 3+ respectively and N be the total number of 
patches generated from a WSI.  
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If n3/N > 0.08: 
        predict 3+ 
else if n2/N > 0.4: 
        predict 2+ 
else if n1/N > 0.14: 
        predict 1+ 
else: 
        predict 0 
 
Percentage of Complete Membrane Staining (PCMS): To estimate the PCMS, first tumor 
regions were identified by extracting the morphological features from tumor and normal 
regions of H&E images.  
After performing stain normalisation [14], the hematoxylin channel was extracted to segment 
the nuclei using Otsu thresholding. Further, nuclei contours were fit around each individual 
structure and filtered on basis of area and eccentricity. This resulted in tumor identification 
regions by detecting the tumour nuclei based on their roundness and size. In order to estimate 
the extent of membrane staining, the morphological features were extracted from an IHC 
image. In addition, a contagious chicken-wire pattern was observed for complete membrane 
stained regions whereas other tissue components result in a fragmented/broken-up skeleton. 
Further, by filling holes in the chicken-wire skeleton and by measuring similarity with the 
original binary image the extent of membrane staining was estimated. 
The PCMS is estimated by calculating the ratio between extent of membrane staining and 
tumor identification regions as given below.  
𝑃𝐶𝑀𝑆 =  
 extent of membrane staining 
tumor identification regions
 𝑥 100      
39 
 
MUCS 
In this submission, the well-known neural networks Alexnet [15]and GoogLeNet [16] were 
adapted by adjusting the layer specific parameters, such as kernel size, stride, and padding. 
There were three submissions from the MUCS team with two submissions using Alexnet 
(MUCS-1 and MUCS-2) and one using GoogLeNet (MUCS-3). 
Training: The training dataset was obtained by hand-picking the regions of interest from 52 
training IHC images that were considered to contain the most representative samples from each 
class. The regions were selected from the low resolution (0.625×) and mapped to the highest 
resolution (40×) whereupon each region was divided into 128 x 128 pixel patches. 
The MUCS-1 trained network had four output classes with corresponding Her2 scores from 0 
to 3+. MUCS-2 and MUCS-3 had an additional output class for the background. The 
background class contained the regions with texture having only a weak appearance of nuclei 
(without blueish or brownish colour).  The training dataset for MUCS-2 was extended by data 
augmentation (rotation and mirroring) and by adding the hand-picked regions from test images 
(without knowing the classification of the slide it originated from). The total patches for 
MUCS-1, MUCS-2 and MUCS-3 were 29000, 319000 and 33500, respectively. The training 
images were divided between actual training data (75%) and validation data (25%). For all 
three submissions, the base learning rate was set to 0.001, and the learning rate was dropped 
every one-third of the maximum iterations by a factor of 10 (γ=0.1). The mean pixel value was 
subtracted from the training dataset. 
Classification: For testing, the common regions from H&E and IHC were selected at a low 
resolution and those regions were mapped to maximum resolution to generate the patches for 
testing. Further, adaptive thresholding was applied to each patch, with an offset of 10, to 
produce a binary image. If the proportion of ones in the binary image was smaller than a factor 
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of 0.9, then patch was classified with the trained neural network model, otherwise the patch 
was marked as background and therefore did not require classification. The Her2 score for a 
WSI was determined using the classified patches as follows: 
• Score 3+, if patches with class 3 was greater than or equal to 10% of total patches 
• Score 2+, if patches with class 2 was greater than or equal to 10%, or patches with class 
3 was between 1% and 10%, of total patches 
• Score 1+, if patches with class 1 was greater than or equal to 10% of total patches 
• Score 0, otherwise 
The confidence value for each WSI was calculated by averaging the confidence values of each 
patch. PCMS was calculated by summing the number of Score 3+ and 2+ patches and dividing 
the sum by total number of patches (excluding the background) as 
𝑃𝐶𝑀𝑆 = 100(𝑛2 + 𝑛3)(∑ 𝑛𝑠
3
𝑠=0 )
−1   (2) 
where n is the number of patches given score s, s ∈ {0,1,2,3} 
MTB NLP  
A CNN was trained to predict the Her2 score for 128 x 128 patches of the WSI. Furthermore, 
as a post-processing step, a Random Forest model was trained to aggregate an estimated Her2 
score and percentages of cell membrane for the WSI. 
Pre-Processing: In the first, tissue regions were manually annotated at 40× by drawing regions 
from IHC stained slide images. A class label was assigned to each annotated region that 
corresponds to WSI GT score. In total, there were 272 annotated regions with an average size 
of 800 x 800. 
Patch Classification: The architectures similar to Alexnet [15] and VGG-16 [17] were trained 
to predict the Her2 scores but the results were only submitted for the architecture similar to 
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Alexnet. The annotated regions were separated at case level by using 207 regions for training 
and the remaining 65 for validation. Each patch was randomly flipped and rotated to increase 
the training dataset and a dropout layer [18] was positioned to prevent the overfitting. The 
model was trained with a total of 8,575,000 patches and with cross entropy loss. 
For testing, each WSI split in to non-overlapping patches of 128 x 128 and fed in to the trained 
network for predictions. Further, connected component analysis based approach was carried 
out to merge 128 x 128 patches into clusters. For each of the class labels, aggregate metrics 
were computed for the WSI that captured the percent of the slide pixels.  
Aggregate Her2 Score and Percentage: To predict the Her2 score and PCMS process the 
aggregated metrics were computed during the patch classification. These metrics were used as 
predictors for a Random Forest classifier that produces that final class probabilities for each of 
the WSI. The same process was repeated using a Random Forest regressor to estimates for the 
percentage of cells that contained staining. 
The 5-fold cross validation was done on all of the 52 training images. In each fold, all of the 
test images were scored and the predicted scores and percentage estimates were averaged over 
all folds to produce the final estimates.  
VISILAB 
In this method, the state-of-the-art GoogLeNet [16] was implanted to predict the Her2 score 
and the percentage of complete cell membrane. 
Data Preparation: A handcrafted dataset was built. For this purpose, a set of representative 
patches of the four Her2 scoring classes were extracted from the ground truth WSIs. 
Additionally, an extra class was employed to collect background samples. These extracted 
patches from training WSIs were 68 x 68 pixels size each. A total of 5750 patches were selected 
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with an average of 1150 patches per class. The dataset was further split in to training (75%) 
and validation (25%) dataset. 
Training: Among several state-of-art CNNs, GoogLeNet was finally selected for submission 
according to the results on validation dataset. The prepared dataset was used for training, by 
selecting 0.01 as base learning rate, with a decreasing policy over 50 epochs, using the 
Stochastic Gradient Descent. 
Classification: The algorithm takes a WSI and applies a grid technique to obtain the 
corresponding patches, with a similar size than the ones from the training dataset. These are 
later classified with the trained model, whose output is a class prediction and a percentage of 
confidence over that decision. 
Her2 Scoring: Once every single patch is classified, a single class score is provided for the 
WSI. The decision rule takes into account the percentage of patches that belongs to each class 
(omitting the background, which was treated as a separate class) using the following criteria: 
starting from class 3+ to class 1+, the first one to achieve at least 10% of patches is chosen as 
final decision. Regarding the percentage of cells with full membrane staining, an expert rule 
was developed. The knowledge basis came from the alternative techniques that were also 
developed, such as the calculation of the staining density for the nuclei. As a result, a 
relationship between the classes percentage distribution and the percentage of membrane cell 
staining was discovered. 
UCCSSE 
This method is based on characteristics curves, a novel feature descriptor for predicting the 
Her2 score.  In pre-processing phase, five regions of interest (ROI) were extracted from each 
WSI, each of size 1800 x 1200 at 20×. The only condition for selecting the ROIs was to select 
those regions that should not contain more than 30 % pixels as background. 
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The segmentation step consists of identifying the tissue portion including the IHC stained 
membrane. The selected ROIs were first segmented in HSB and CIELab colour spaces. In 
addition, some colour filters and neighbourhood masks were used to segment the connective 
tissues and fat lobules that should be separated before calculating the PCMS.  
 
Fig 1: Characteristics curves and the corresponding Her2 score. The x-axis denotes range of 
the saturation value whereas y-axis denotes the calculated percentage from saturation limits. 
The predicted Her2 scores are also shown for each curve. 
The essential part for the classification algorithm was the extraction of a characteristics curve 
for selected ROIs. The percentage-saturation characteristics curve was generated by varying 
the saturation limits from [0.1, 1] to [0.5, 1] in 20 steps by keeping the hue fixed. To plot the 
characteristics curve the percentage of stained region was calculated for each step by taking 
the ratio between segmented pixels to the number of pixels in an ROI. The characteristics 
curves have high discriminative appearance as shown in Fig 1. The curve always represents a 
smooth polynomial curve that can be accurately modelled using a cubic polynomial (best fit).  
 
It was also observed during experimental analysis that when the Her2 score is 1+, the starting 
region of the curve always starts above the 10% mark depicting the presence of weak and 
incomplete membrane staining of regions. For 3+ score, the curves were lying above the 30% 
mark that shows the existence of an intense and uniform membrane staining areas.  
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RumRocks 
In this approach, the two-dimensional (2D) CNN [15,19] models were trained for pre-
processing and classification. First, as pre-processing step each WSI processed using 
deconvolution neural network (DCNN) and following by a CNN1 to select the desired patches. 
Furthermore, the selected patches were processed through a CNN2 to predict the Her2 score 
and the PCMS. 
Patch Selection: A low resolution representation of a WSI (0.3125×) was selected and passed 
through a DCNN to segment the tissue components. Next, the detected regions were divided 
into patches with only condition that selected patches should contain 50% or more region from 
area of interest. The subsampled patch coordinates were translated to 10× resolution for further 
processing. The CNN1 trained to accept or reject a subsampled patch based on its 
morphological appearance. The overview of neural network architectures are as given below 
𝐷𝐶𝑁𝑁1 = {𝐷1, 𝐷1, … … , 𝐷6 − 𝑈1, 𝑈2, … … , 𝑈5 − 𝐶2𝐷3\1 −  𝑆𝑔  } 
𝐶𝑁𝑁1 = {𝐷1, 𝐷1, … … , 𝐷7 − 𝑅𝑒𝑠ℎ𝑎𝑝𝑒 −  𝐹𝐶 −  𝑆𝑔  }  (3) 
The notation of the architecture is as follows, 𝐷1 represents the down-sampling convolutional 
whereas 𝑈1 represents the up-sampling convolutional layer with 3 as kernel size and 1 as stride. 
After convolutional operations batch normalization, ReLu and max pooling operations were 
applied. 𝐹𝐶 represents fully connected layers and 𝑆𝑔 represents sigmoid function. 
Classification: For predicting the Her2 score and PCMS, a CNN2 with combination of residual 
layers [20] was employed. The batch dimensions were exploited in order to feed in multiple 
patches from the same WSI simultaneously. Instead of combining the prediction of individual 
patches through averaging or aggregating metrics, a tensor was reshaped to a vector once the 
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spatial size has been significantly reduced and forward it through a 1D convolution layer. The 
overview of architecture CNN2 is given below  
𝐶𝑁𝑁2 = {𝐶2𝐷3\1 −  𝑟𝑒𝑠𝐵1, … … , 𝑟𝑒𝑠𝐵7 − 𝑓𝑙𝑎𝑡𝑡𝑒𝑛 − 𝐶1𝐷1\1, − 𝐹𝐶1 − 𝐹𝐶2 − 𝑆𝑔  }  (4) 
The CNN models were trained using the mean squared error loss function and the Adam 
stochastic gradient decent optimization method with initial learning rate of 10-3. The learning 
rate was reduced every 15,000 iterations by a factor of 1.5 and trained each network for between 
200,000 – 300,000 iterations. The average was calculated for each networks prediction to form 
an ensemble based score. 
FSUJena 
The algorithm for automated Her2 scoring was based on Alexnet [15] CNN. In this method, an 
activation matrix was extracted after convolution layers to compute the bilinear filters for 
predicting the Her2 score and PCMS. 
At the first, ROIs were manually probed and patches of size 227 x 227 were randomly extracted 
at 20×. The pre-trained version of Alexnet was used from ImageNet dataset for further training 
on contest dataset. For each patch in the training dataset, an activation matrix was extracted 
after convolutional layers. The activations can be represented as a tensor 𝑥 ∈  ℝ𝑤 × ℎ × 𝑑  
comprised of d-dimensional vectors in a 𝑤 ×ℎ spatial grid. The bilinear features [21,22] were 
further computed as the Gramian 𝐺 matrix by summing up dyadic products along the spatial 
dimensions:  𝐺 =   ∑ 𝑥𝑖,𝑗𝑖,𝑗  , 𝑥𝑖,𝑗
𝑇 . The matrix 𝐺 contains the second-order statistics of the CNN 
features and have been found to be extremely useful for fine-grained recognition tasks. Then 
the square root and 𝐿2normalization of 𝐺 were employed to increase the numerical stability of 
further processing steps [22].  To differentiate among four scoring classes a multi-class logistic 
regression was used. It was also observed that using a pre-trained network on ImageNet dataset 
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is also beneficial to avoid the overfitting issues. In preliminary results the bilinear features 
approach outperformed the conventional CNN activations. 
For testing a WSI and to predict the Her2 score, an average was calculated for all the random 
crops patches. To predict the PCMS the mean tumour cell percentage seen in the training set 
of for a particular class as an estimate.    
Huang’s Method (Huangch) 
In this approach, a range of handcrafted features extracted from the IHC stained slides after 
performing the stain deconvolution. The handcrafted features were then fed in to a model of 
multi-class AdaBoosted decision trees. 
Sampling: At the first, control tissue was extracted to developed a pseudo color space for stain 
deconvolution [23] to obtain the two staining vectors. Further, mean filtering was performed 
to record the local maximal points. The patches were selected from each WSI on the basis of 
local maximal points as they were representing the strongest Her2 stained over-expression 
signals 
Feature Extraction and Classification: A combined but numerically independent features 
vector space constructed by including Gabor Filtering, Features of Fractal Dimension by 
Differential Box-Counting [23], multi-wavelet methods, histogram statics methods, grey-level 
(over all colour channels) co-occurrence based methods [24,25] etc.  
For predicting the Her2 score and the PCMS, a model of multi-class AdaBoosted decision-
trees was employed to map the features vector of each patch to a predicted value. This model 
is known as Stagewise Additive Modelling using a Multi-class Exponential [26] loss function 
(SAMME).  The model composed by a series of decision-trees by assigning a weight to each 
decision-tree. Whereas while training, a pool of decision-trees generated and after each 
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iteration the best decision-tree was selected with its corresponding weight. After certain 
iterations, a group of decision-trees was selected for testing phase.   
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